North American Bariatric Surgery Market - Growth, Trends and Forecasts 2017 - 2022 - Product Image

North American Bariatric Surgery Market - Growth, Trends and Forecasts 2017 - 2022

  • ID: 4387321
  • Report
  • Region: North America, United States
  • 107 pages
  • Mordor Intelligence
1 of 3
The North America Bariatric Surgery Market has been estimated at USD 528 million in 2014 and is projected to reach USD 1,035 million by 2020, at a CAGR of 11.6% during the forecast period from 2014 to 2021. Bariatric surgery is a procedure of weight loss performed in obese people. The surgical procedure includes both invasive and non invasive techniques and can be performed in both open and laparoscopic types.

The bariatric surgery causes significant long-term loss of weight, recovery from diabetes, improvement in cardiovascular risk factors and a significant reduction in mortality. It has also been found that psychological health can improve after a bariatric surgery in patients with severe depression due to their weight concerns. . The U.S. National Institutes of Health recommends bariatric surgery for obese people with a body mass index (BMI) of at least 40, and for people with BMI 35 and serious coexisting medical conditions such as diabetes.

The market is driven by a number of factors like a steady increase in the number of obese patients high prevalence rate of Type 2 Diabetes and heart ailments, emerging Government initiatives to curb obesity, changes in insurance policy, public awareness, improved surgical training and a shift in trends to fast food and sedentary lifestyle. However, the market is restrained by the high cost affiliated to the surgical procedure, post surgery complications like gastrointestinal ulcers or bleeding, small bowel obstruction and hernia and the preference and the rapid growth of weight loss diet like food, low calorie beverages and supplements.

The bariatric surgery market can be broadly segmented on the basis of products and type of surgery. The product segment is further sub segmented into adjustable gastric bands (realize band, lap band, heliogast and midband), intragastric balloons, implantable gastric stimulators, two techniques, surgical clamps, gastric surgery clamps, clip appliers, endo stitch and surgical staples and trocars. Based on the type it is sub segmented as gastric bypass, gastric banding and sleeve gastrectomy.

The North America bariatric Surgery Market has been broadly divided geographically into the USA and Canada market.

The key players in the bariatric surgery market in North America are Covidien plc, Ethicon Endo-Surgery Inc., Allergan Inc., EndoGastric Solutions, Inc. , GI Dynamics among many others.

Key Deliverables:

Market analysis for the North America Bariatric Surgery Market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale

Extensively researched competitive landscape section with profiles of major companies along with their market shares

Identification and analysis of the macro and micro factors that affect the North America Bariatric Surgery Market

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.2.1 Market Size and Share
1.2.2 Markets Covered
1.2.3 Stakeholders
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.1 General overview of bariatric Procedures
3.2 Laparoscopic vs Open Surgery
3.3 Types of Bariatric Procedures
3.3.1 Malabsorptive
3.3.2 Restrictive Procedures
3.3.3 Combined Restrictive/ Malabsorptive
3.4 New Bariatric procedures
3.4.1 PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE) PROCEDURE
3.4.2 RESTORATIVE OBESITY SURGERY ENDOSCOPIC (ROSE) PROCEDURE
3.5 Market Drivers
3.5.1 Increase in Obesity Patients
3.5.2 Prevalence rate of Type 2 Diabetes and Heart Diseases
3.5.3 Government Initiatives to curb Obesity
3.5.4 Insurance Coverage
3.5.5 Public awareness
3.5.6 Surgical Training
3.5.7 Shift in trends to Fast Food and sedentory lifestyle.
3.6 Market Constraints
3.6.1 Lack of knowledge and awareness in developing countries
3.6.2 Less disposable income in developing nations
3.6.3 High cost of surgery
4. MARKET SEGMENTATION
4.1 Bariatric Surgery Devices, By Products
4.1.1 Adjustable Gastric Bands
4.1.1.1 Realize band
4.1.1.2 Lap Band
4.1.1.3 Heliogast(Outside US)
4.1.1.4 Midband(Outside US)
4.1.2 Intragastric balloons
4.1.3 Implantable gastric Simulators
4.1.4 Two Techniques
4.1.4.1 Disrupting motility
4.1.4.2 Enteric nervous stimulation
4.1.5 Surgical Clamps
4.1.6 Gastric Surgery Clamps
4.1.7 Clip Appliers
4.1.8 Endo Stitch
4.1.9 Surgical Staples and trocars
4.2 Bariatric Surgery Devices, By Geography
4.2.1 US
4.2.2 Canada
4.3 US market is analysed by segments
4.3.1 Gastric Bypass
4.3.2 Gastric Banding
4.3.3 Sleeve Gastrectomy
5. COMPETIION LANDSCAPE
5.1 INTRODUCTION
5.2 MERGERS & ACQUISITIONS
5.3 AGREEMENTS & COLLABORATIONS
5.4 NEW PRODUCT DEVELOPMENTS
5.5 OTHER DEVELOPMENTS
6. TOP 3 COMPANIES
6.1 Covidien plc
6.1.1 Profile
6.1.2 Major Products
6.1.3 Recent Developments
6.1.4 Market Strategies
6.2 Ethicon Endo-Surgery, Inc.
6.2.1 Profile
6.2.2 Major Products
6.2.3 Recent Developments
6.2.4 Market Strategies
6.3 Allergan, Inc.
6.3.1 Profile
6.3.2 Major Products
6.3.3 Recent Developments
6.3.4 Market Strategies
7. COMPANY PROFILES
7.1 Allergan, Inc.
7.2 Covidien PLC
7.3 EndoGastric Solutions, Inc.
7.4 EnteroMedics, Inc.
7.5 GI Dynamics, Inc.
7.6 Intuitive Surgical, Inc.
7.7 Johnson & Johnson
7.8 ReShape Medical, Inc
7.9 Satiety, Inc.
7.10 Spatz FGIA, Inc.
7.11 TransEnterix, Inc.
7.12 USGI Medical, Inc.
8. Appendix
8.1. Abbreviations
8.2. Sources
8.3. Bibliography
8.4. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll